Revvity | PKI - Gross Profit On Sales


Revvity reported $387.66M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Agilent USD 990M 44M Mar/2026
Align Technology USD 736.59M 53M Mar/2026
Bio Techne USD 208.29M 17.01M Mar/2026
Bio-Rad Laboratories USD 345.2M 1.8M Dec/2025
Bruker USD 379.8M 69.4M Mar/2026
Celltrion KRW 46.98B 579.12B Dec/2025
Charles River Laboratories USD 279.32M 7.36M Mar/2026
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Danaher USD 3.59B 375M Mar/2026
Dentsply International USD 427M 16M Mar/2026
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Dianthus Therapeutics USD 284K 112K Dec/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Edwards Lifesciences USD 1.29B 59.4M Mar/2026
Illumina USD 721M 38M Mar/2026
Intuitive Surgical USD 1.83B 73.8M Mar/2026
IQVIA Holdings USD 1.07B 52M Mar/2026
Kangmei Pharma CNY 238.34M 31.95M Mar/2026
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Laboratory Of America USD 1.01B 20.6M Mar/2026
Medical Developments International AUD 7.35M 7.37M Jun/2025
Mesa Laboratories USD 39.75M 4.3M Dec/2024
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Myriad Genetics USD 146.8M 3M Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pacific Biosciences Of California USD 15.74M 601K Dec/2025
Pharma Mar EUR 39.24M 47.46M Mar/2026
Qiagen NV USD 325.27M 19.53M Dec/2025
Quest Diagnostics USD 906M 33M Mar/2026
Quidel USD -91.8M 366.6M Mar/2026
Repligen USD 108.28M 4.45M Mar/2026
Revvity USD 387.66M 34M Mar/2026
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Thermo Fisher Scientific USD 4.49B 146M Mar/2026
Tilray USD 57.47M 10.16M Jun/2025
Waters USD 542M 15.42M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026